FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044897449> ?p ?o ?g. }

• W3044897449 endingPage "2081.e6" @default.
• W3044897449 startingPage "2072" @default.
• W3044897449 abstract "Background & Aims The association between atopic diseases and inflammatory bowel diseases (IBD) is unclear. We conducted a nationwide population-based study in Korea to investigate the effect of atopic diseases on the development of IBD. Methods A total of 9,923,521 participants, who received a medical check-up in 2009, were included and followed through 2017. The presence of any atopic diseases, including atopic dermatitis (AD), allergic rhinitis (AR), and asthma, was evaluated. Patients who developed IBD, including Crohn’s disease (CD) and ulcerative colitis (UC), were identified using claims data from National Health Insurance; the association between atopic diseases and the risk of IBD was evaluated using Cox proportional hazard models, and presented as adjusted hazard ratios (aHRs) with 95% CIs. Results During a mean follow-up period of 7.3 years, 1419 patients (0.014%) developed CD and 5897 patients (0.059%) developed UC. The incidences of CD (per 100,000 person-years) were 3.756, 2.248, and 2.346 in patients with AD, AR, or asthma, respectively. The incidences of UC were 11.952, 9.818, and 9.358 in patients with AD, AR, or asthma, respectively. Multivariable analysis revealed that the aHRs for incident CD in patients with AD, AR, or asthma were 2.02, 1.33, and 1.60 (95% CIs, 1.118–3.663, 1.149–1.529, and 1.193–2.136, respectively) compared with controls. The risks of incident UC in patients with AD, AR, or asthma were 1.51, 1.32, and 1.29 (95% CIs, 1.082–2.104, 1.229–1.410, and 1.115–1.491, respectively) compared with controls. Moreover, an increase in the number of atopic diseases gradually increased the risk for CD and UC; for 1 or 2 or more atopic diseases, the aHRs for CD were 1.35 and 1.65 (95% CIs, 1.171–1.560 and 1.146–2.376), and the aHRs for UC were 1.30 and 1.49 (95% CIs, 1.211–1.392 and 1.249–1.774), respectively. Conclusions Based on a nationwide population-based study in Korea, patients with any atopic disease, including AD, AR, or asthma, have an increased risk for CD and UC. The risk for IBD increases with the increase in the number of atopic diseases. The association between atopic diseases and inflammatory bowel diseases (IBD) is unclear. We conducted a nationwide population-based study in Korea to investigate the effect of atopic diseases on the development of IBD. A total of 9,923,521 participants, who received a medical check-up in 2009, were included and followed through 2017. The presence of any atopic diseases, including atopic dermatitis (AD), allergic rhinitis (AR), and asthma, was evaluated. Patients who developed IBD, including Crohn’s disease (CD) and ulcerative colitis (UC), were identified using claims data from National Health Insurance; the association between atopic diseases and the risk of IBD was evaluated using Cox proportional hazard models, and presented as adjusted hazard ratios (aHRs) with 95% CIs. During a mean follow-up period of 7.3 years, 1419 patients (0.014%) developed CD and 5897 patients (0.059%) developed UC. The incidences of CD (per 100,000 person-years) were 3.756, 2.248, and 2.346 in patients with AD, AR, or asthma, respectively. The incidences of UC were 11.952, 9.818, and 9.358 in patients with AD, AR, or asthma, respectively. Multivariable analysis revealed that the aHRs for incident CD in patients with AD, AR, or asthma were 2.02, 1.33, and 1.60 (95% CIs, 1.118–3.663, 1.149–1.529, and 1.193–2.136, respectively) compared with controls. The risks of incident UC in patients with AD, AR, or asthma were 1.51, 1.32, and 1.29 (95% CIs, 1.082–2.104, 1.229–1.410, and 1.115–1.491, respectively) compared with controls. Moreover, an increase in the number of atopic diseases gradually increased the risk for CD and UC; for 1 or 2 or more atopic diseases, the aHRs for CD were 1.35 and 1.65 (95% CIs, 1.171–1.560 and 1.146–2.376), and the aHRs for UC were 1.30 and 1.49 (95% CIs, 1.211–1.392 and 1.249–1.774), respectively. Based on a nationwide population-based study in Korea, patients with any atopic disease, including AD, AR, or asthma, have an increased risk for CD and UC. The risk for IBD increases with the increase in the number of atopic diseases." @default.
• W3044897449 created "2020-07-29" @default.
• W3044897449 creator A5000521813 @default.
• W3044897449 creator A5007393427 @default.
• W3044897449 creator A5009695671 @default.
• W3044897449 creator A5016617540 @default.
• W3044897449 creator A5046358924 @default.
• W3044897449 creator A5047846074 @default.
• W3044897449 creator A5052434732 @default.
• W3044897449 creator A5056628655 @default.
• W3044897449 creator A5066397554 @default.
• W3044897449 creator A5069425218 @default.
• W3044897449 creator A5084473082 @default.
• W3044897449 date "2021-10-01" @default.
• W3044897449 modified "2023-10-15" @default.
• W3044897449 title "Atopic Diseases Are Associated With Development of Inflammatory Bowel Diseases in Korea: A Nationwide Population-based Study" @default.
• W3044897449 cites W1088236639 @default.
• W3044897449 cites W1116183837 @default.
• W3044897449 cites W1978768695 @default.
• W3044897449 cites W1987627943 @default.
• W3044897449 cites W2005553679 @default.
• W3044897449 cites W2040693077 @default.
• W3044897449 cites W2065132595 @default.
• W3044897449 cites W2069040728 @default.
• W3044897449 cites W2077990797 @default.
• W3044897449 cites W2097901958 @default.
• W3044897449 cites W2099423112 @default.
• W3044897449 cites W2103169988 @default.
• W3044897449 cites W2108445560 @default.
• W3044897449 cites W2120793327 @default.
• W3044897449 cites W2137914700 @default.
• W3044897449 cites W2147279704 @default.
• W3044897449 cites W2158172054 @default.
• W3044897449 cites W2182793977 @default.
• W3044897449 cites W2189045271 @default.
• W3044897449 cites W2191163222 @default.
• W3044897449 cites W2300983989 @default.
• W3044897449 cites W2536753757 @default.
• W3044897449 cites W2538187733 @default.
• W3044897449 cites W2586959160 @default.
• W3044897449 cites W2588997555 @default.
• W3044897449 cites W2754902043 @default.
• W3044897449 cites W2777011462 @default.
• W3044897449 cites W2789799903 @default.
• W3044897449 cites W2793722620 @default.
• W3044897449 cites W2808249516 @default.
• W3044897449 cites W2946435078 @default.
• W3044897449 cites W2967698737 @default.
• W3044897449 cites W2985969672 @default.
• W3044897449 cites W4234433941 @default.
• W3044897449 cites W4292198229 @default.
• W3044897449 doi "https://doi.org/10.1016/j.cgh.2020.07.049" @default.
• W3044897449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32712393" @default.
• W3044897449 hasPublicationYear "2021" @default.
• W3044897449 type Work @default.
• W3044897449 sameAs 3044897449 @default.
• W3044897449 citedByCount "7" @default.
• W3044897449 countsByYear W30448974492021 @default.
• W3044897449 countsByYear W30448974492022 @default.
• W3044897449 countsByYear W30448974492023 @default.
• W3044897449 crossrefType "journal-article" @default.
• W3044897449 hasAuthorship W3044897449A5000521813 @default.
• W3044897449 hasAuthorship W3044897449A5007393427 @default.
• W3044897449 hasAuthorship W3044897449A5009695671 @default.
• W3044897449 hasAuthorship W3044897449A5016617540 @default.
• W3044897449 hasAuthorship W3044897449A5046358924 @default.
• W3044897449 hasAuthorship W3044897449A5047846074 @default.
• W3044897449 hasAuthorship W3044897449A5052434732 @default.
• W3044897449 hasAuthorship W3044897449A5056628655 @default.
• W3044897449 hasAuthorship W3044897449A5066397554 @default.
• W3044897449 hasAuthorship W3044897449A5069425218 @default.
• W3044897449 hasAuthorship W3044897449A5084473082 @default.
• W3044897449 hasConcept C126322002 @default.
• W3044897449 hasConcept C203014093 @default.
• W3044897449 hasConcept C207103383 @default.
• W3044897449 hasConcept C2776042228 @default.
• W3044897449 hasConcept C2777572184 @default.
• W3044897449 hasConcept C2778260677 @default.
• W3044897449 hasConcept C2778329239 @default.
• W3044897449 hasConcept C2779134260 @default.
• W3044897449 hasConcept C2780479503 @default.
• W3044897449 hasConcept C2908647359 @default.
• W3044897449 hasConcept C44249647 @default.
• W3044897449 hasConcept C71924100 @default.
• W3044897449 hasConcept C90924648 @default.
• W3044897449 hasConcept C99454951 @default.
• W3044897449 hasConceptScore W3044897449C126322002 @default.
• W3044897449 hasConceptScore W3044897449C203014093 @default.
• W3044897449 hasConceptScore W3044897449C207103383 @default.
• W3044897449 hasConceptScore W3044897449C2776042228 @default.
• W3044897449 hasConceptScore W3044897449C2777572184 @default.
• W3044897449 hasConceptScore W3044897449C2778260677 @default.
• W3044897449 hasConceptScore W3044897449C2778329239 @default.
• W3044897449 hasConceptScore W3044897449C2779134260 @default.
• W3044897449 hasConceptScore W3044897449C2780479503 @default.
• W3044897449 hasConceptScore W3044897449C2908647359 @default.
• W3044897449 hasConceptScore W3044897449C44249647 @default.
• W3044897449 hasConceptScore W3044897449C71924100 @default.

• next